Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items

Work isn't working: Family, work and progression on a low income
Most children in poverty in the UK are in working households, a phenomenon that has emerged since the early 2000s.
The government is about to host a ‘Global Partnership Conference’ – should it even bother?
Tomorrow, the government is hosting the Global Partnership Conference in East London.
Diversifying diplomacy: UK strategy in a fragmenting world
How the UK might build more durable international partnerships in energy, defence and technology.